These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7554704

  • 1. Azithromycin and terfenadine: lack of drug interaction.
    Harris S, Hilligoss DM, Colangelo PM, Eller M, Okerholm R.
    Clin Pharmacol Ther; 1995 Sep; 58(3):310-5. PubMed ID: 7554704
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR, Barbey JT, Franc J, Brown KS, Feirrera I, Ford N, Salazar DE.
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [Abstract] [Full Text] [Related]

  • 4. Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men.
    Martin DE, Zussman BD, Everitt DE, Benincosa LJ, Etheredge RC, Jorkasky DK.
    J Clin Psychopharmacol; 1997 Dec; 17(6):451-9. PubMed ID: 9408807
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine.
    Awni WM, Cavanaugh JH, Leese P, Kasier J, Cao G, Locke CS, Dube LM.
    Eur J Clin Pharmacol; 1997 Dec; 52(1):49-54. PubMed ID: 9143867
    [Abstract] [Full Text] [Related]

  • 8. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram.
    Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL.
    Clin Pharmacol Ther; 1996 Apr; 59(4):383-8. PubMed ID: 8612381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Fexofenadine: a antihistaminic. Review of its practical characteristics].
    Caballero E, Ocaña I, Azanza JR, Sádaba B.
    Rev Med Univ Navarra; 1999 Apr; 43(2):93-7. PubMed ID: 11256010
    [No Abstract] [Full Text] [Related]

  • 15. Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo.
    Goldberg MJ, Ring B, DeSante K, Cerimele B, Hatcher B, Sides G, Wrighton S.
    J Clin Pharmacol; 1996 Dec; 36(12):1154-60. PubMed ID: 9013373
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadine.
    Stern RH, Smithers JA, Olson SC.
    J Clin Pharmacol; 1998 Aug; 38(8):753-7. PubMed ID: 9725552
    [Abstract] [Full Text] [Related]

  • 17. Lack of effect of terfenadine on the pharmacokinetics of the CYP3A4 substrate buspirone.
    Lamberg TS, Kivistö KT, Neuvonen PJ.
    Pharmacol Toxicol; 1999 Apr; 84(4):165-9. PubMed ID: 10227067
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular safety of fexofenadine HCl.
    Pratt CM, Mason J, Russell T, Reynolds R, Ahlbrandt R.
    Am J Cardiol; 1999 May 15; 83(10):1451-4. PubMed ID: 10335761
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.